A la recherche de nouvelles thérapeutiques
707
to rat liver: an effective strategy to prevent
bone deposition and increase urine elimination of plutonium in rats. Int J Radiat
Biol, 80 :413-422.
Phan G, Le Gall B, Grillon G, Rouit E, Fouillit
M, Benech H, Fattal E, Deverre JR (2006).
Enhanced decorporation of plutonium by
DTPA encapsulated in small PEG-coated
liposomes. Biochimie, 88 : 1843-1849.
Ramounet-Le Gall b, Grillon G, Rateau G,
Burgada R, Bailly T, Fritsch P (2003).
Comparative decorporation efficacy of
3,4,3-LIHOPO, 4,4,4-LIHOPO and DTPA
after contamination of rats with soluble forms of 238Pu and 233U. Radiat Prot
Dosim, 105 : 535-538.
Sawicki M, Siaugue J-M, Jacopin C, Moulin
C, Bailly T, Burgada R, Meunier S, Baret
P, Pierre J-L, Taran F (2005). Discovery
of powerful uranyl ligands from efficient
synthesis and screening. Chem Eur J, 11 :
3689-3697.
Sawicki M, Lecerclé D, Grillon G, le Gall b,
Sérandou AL, Poney JL, Bailly T, Burgada R, Lecouvey M, Challeix V, Leydier
A, Pellet-Rostaing S, Ansoborlo E, Taran
F (2008). Bisphosphonate sequestering
agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI)
chelation. Eur J Med Chern, 43 : 27682777.
Sérandour AL, Grémy O, Fréchou M, Renault
D, Poney JL, Fritsch P (2008). In vitro and
in vivo assessment of plutonium speciation and decorporation in blood and target
retention tissues after a systemic contamination followed by an early treatment with
DTPA. Radiat Res, 170 : 208-215.
Wang L, Yang Z, Gao J, Xu K, Gu H, Zhang
B, Zhang X, Xu B (2006). A biocompatible method of decorporation: bisphosphonate-modified magnetite nanoparticles
to remove uranyl ions from blood. JACS,
128 : 13358-13359.
707
to rat liver: an effective strategy to prevent
bone deposition and increase urine elimination of plutonium in rats. Int J Radiat
Biol, 80 :413-422.
Phan G, Le Gall B, Grillon G, Rouit E, Fouillit
M, Benech H, Fattal E, Deverre JR (2006).
Enhanced decorporation of plutonium by
DTPA encapsulated in small PEG-coated
liposomes. Biochimie, 88 : 1843-1849.
Ramounet-Le Gall b, Grillon G, Rateau G,
Burgada R, Bailly T, Fritsch P (2003).
Comparative decorporation efficacy of
3,4,3-LIHOPO, 4,4,4-LIHOPO and DTPA
after contamination of rats with soluble forms of 238Pu and 233U. Radiat Prot
Dosim, 105 : 535-538.
Sawicki M, Siaugue J-M, Jacopin C, Moulin
C, Bailly T, Burgada R, Meunier S, Baret
P, Pierre J-L, Taran F (2005). Discovery
of powerful uranyl ligands from efficient
synthesis and screening. Chem Eur J, 11 :
3689-3697.
Sawicki M, Lecerclé D, Grillon G, le Gall b,
Sérandou AL, Poney JL, Bailly T, Burgada R, Lecouvey M, Challeix V, Leydier
A, Pellet-Rostaing S, Ansoborlo E, Taran
F (2008). Bisphosphonate sequestering
agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI)
chelation. Eur J Med Chern, 43 : 27682777.
Sérandour AL, Grémy O, Fréchou M, Renault
D, Poney JL, Fritsch P (2008). In vitro and
in vivo assessment of plutonium speciation and decorporation in blood and target
retention tissues after a systemic contamination followed by an early treatment with
DTPA. Radiat Res, 170 : 208-215.
Wang L, Yang Z, Gao J, Xu K, Gu H, Zhang
B, Zhang X, Xu B (2006). A biocompatible method of decorporation: bisphosphonate-modified magnetite nanoparticles
to remove uranyl ions from blood. JACS,
128 : 13358-13359.